The protection offered by the Oxford-Astra Zeneca Covid-19 vaccine declines after three months of receiving two doses, a study says. The findings – drawn from datasets in two countries – suggest that…




The protection offered by the Oxford-Astra Zeneca Covid-19 vaccine declines after three months of receiving two doses, a study says. The findings – drawn from datasets in two countries – suggest that…


Israeli ministers on Monday agreed to ban travel to the United States, Canada and eight other countries amid the rapid, global spread of the omicron variant. Prime Minister Naftali Bennett’s office announced…
A series of recently published preclinical study results show that the Spike Ferritin Nanoparticle (SpFN) COVID-19 vaccine developed by researchers at the Walter Reed Army Institute of Research (WRAIR) not only elicits a potent…


Muscles appear to grow, rather than shrink, in some critically ill COVID-19 patients, finds new research being presented at Euroanaesthesia, the annual meeting of the European Society of Anaesthesiology and Intensive Care…


An additional 100,000 elective operations could be cancelled in England this winter as a result of the Omicron wave leading to increased hospital admissions, a new study reveals. The modelling study, published…


Twenty-one months into the global pandemic, millions of Americans continue to believe misinformation about vaccination and Covid-19, and these beliefs are associated with hesitancy to get themselves and their children vaccinated –…


Small, unique antibody-like proteins known as VNARs — derived from the immune systems of sharks — can prevent the virus that causes COVID-19, its variants, and related coronaviruses from infecting human cells,…
An analysis of data from 16 U.S. states suggests that the first few months of the COVID-19 pandemic saw increases in wine and spirit sales, accompanied by notable changes in the relationship…


Why do 80 to 90% of people infected with COVID-19 experience only mild cases while 10 to 20% face more severe or life-threatening symptoms? Researchers in the lab of Yale’s Richard Flavell…